160 results on '"Gomez-Almaguer, D"'
Search Results
2. Guías del manejo de trastornos de coagulación en pacientes con cirrosis
3. Blood transfusion in children at a university hospital in a middle-income country: The need to reinforce adherence to current guidelines
4. Bone marrow architecture reconstitution after hematopoietic grafting: A cross-sectional study
5. Current state and perspectives of stem cell therapy for stroke
6. Hairy cell leukemia, an uncommon B-cell lymphoid neoplasia
7. Thrombotic thrombocytopenic purpura
8. Latin America: the next region for haematopoietic transplant progress
9. PB1762: PONATINIB VERSUS IMATINIB WITH REDUCED-INTENSITY CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME–POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): PHALLCON STUDY
10. P838: PEGCETACOPLAN RAPIDLY STABILIZES COMPLEMENT INHIBITOR NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA EXPERIENCING HEMOLYSIS WITH ACUTE HEMOGLOBIN DECREASES; PRINCE TRIAL POST HOC ANALYSIS
11. S303: EFFECT OF PEGCETACOPLAN ON QUALITY OF LIFE IN COMPLEMENT-INHIBITOR NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE PHASE 3 PRINCE STUDY
12. PB1982: DEEPENING OF RESPONSE IN PATIENTS WITH MULTIPLE MYELOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: A MULTICENTRIC STUDY IN A LATINO POPULATION
13. IMMUNOPHENOTYPIC CHARACTERIZATION OF THE FIRST CD19+ CAR-T CELLS IN MEXICO
14. Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial
15. Hematopoietic stem cell transplant activity in Latin America: Predominant increase in autologous and modest increase in allogeneic HCT with high use of unrelated cord blood grafts: 402
16. Outpatient haploidentical peripheral blood stem-cell transplantation with post-transplant cyclophosphamide in children and adolescents: 403
17. Observational study of multiple myeloma in Latin America: 302
18. Low-dose rituximab, eltrombopag and highdose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults: 109
19. Ponatinib Versus Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL): PhALLCON Study
20. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials.
21. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
22. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
23. Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study
24. Erratum: Latin America: the next region for haematopoietic transplant progress
25. Ponatinib vs Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive (Ph plus ) ALL: PhALLCON Study
26. Hematopoietic stem cell transplants for persons with multiple sclerosis: Is this the best therapeutic option?
27. Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial
28. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: From the perspective of a large group of CML experts
29. Radiotherapeutic Techniques in Allogeneic Hematopoietic Cell Transplant (HCT)
30. Trends in Utilization of Total Body Irradiation (TBI) Prior to Hematopoietic Cell Transplantation (HCT) Worldwide
31. Therapy of Steroid-Refractory Chronic GVHD with Subcutaneous Low-Dose Alemtuzumab and Rituximab Combination Is Effective and Safe
32. Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease
33. TP2 Patrones De Tratamiento De La Leucemia Mieloide Crónica (Lmc) En Pacientes Resistentes O Intolerantes A Imatinib En Instituciones De Salud Pública En México
34. PSY24 COST OF CARE FOR CHRONIC MYELOID LEUKEMIA (CML) IN PATIENTS EXPERIENCING RESISTANCE AND/OR INTOLERANCE TO IMATINIB FROM THE PUBLIC HEALTH SYSTEM PERSPECTIVE IN MEXICO
35. Reduced-Intensity Allogeneic Versus Autologous Peripheral Blood Stem Cell Transplantation In Patients With Hodgkin's and Non-Hodgkin's Lymphoma
36. A Single Apheresis Procedure in the Donor May Be Enough to Complete an Allograft Using the “Mexican Method” of Non-Ablative Allografting
37. 157: Therapeutic Choices in Patients with Ph1 (+) Chronic Myelogenous Leukemia Living in Developing Countries in the Tyrosine Kinase Inhibitors (TKI) Era: Stem Cell Transplantation or TKI?
38. Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience
39. 294: Alemtuzumab in the treatment of steroid refractory acute graft-versus-host disease
40. 268: Umbilical cord blood transplantation using non-myeloablative conditioning
41. 240: Reduced-intensity stem cell transplantation in patients with high-risk acute lymphoblastic leukemia (ALL)
42. Choosing the patient for ambulatory stem cell transplantation
43. Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status
44. Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: The Mexican experience
45. Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute myelogenous leukemia eligible for conventional allografting: results of a prospective, multicenter study
46. Outpatient Stem Cell Transplantation Using a Reduced-Intensity Conditioning in Type 1 Diabetes Mellitus
47. Outpatient HLA-Haploidentical Stem Cell Transplantation in Children Using a Reduced-Intensity Conditioning Regimen and CD3-CD19 Depletion
48. Intrathecal Autologous Total Nucleated Cells for Children With Hipoxic/Ischemic Brain Injury
49. Another Jack in the box. The “academic cartel”… is just our imagination?
50. Effective medicine and the economy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.